Silexion Therapeutics (SLXN) Misses Q3 EPS by 288c
Tweet
Share
E-mailGet Alerts SLXN Hot Sheet
Join SI Premium – FREE
Silexion Therapeutics (NASDAQ: SLXN) reported Q3 EPS of ($2.88).
For earnings history and earnings-related data on Silexion Therapeutics (SLXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silver Lake In Talks To Buy Workday, Sources Say - Reuters
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- Omega Flex (OFLX) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
